Apyx Medical Corporation Financial Ratios — APYX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	0.5	2.74	-33.15	-177.05	67.16	-15.92	-20.98	114.86	-24.88	-17.63	-25.84	-50.79	-58.22	-114.7	-77.99
Return on Assets (%)	0.39	2.19	-14.14	-59.58	-19.08	-11.87	-15.32	98.84	-21.81	-14.98	-21.24	-38.48	-28.57	-32.57	-17.03
Return on Capital (%)	- -	3.03	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	2.98	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	42.23	40.96	38.88	32.48	42.54	58.01	67.99	65.2	67.63	63.17	69.26	65.45	64.49	61.04	62.53
EBITDA Margin (%)	6.88	6.88	-12	-17.97	-20.91	-120.85	-113.98	-77.48	-71.24	-69.27	-27.92	-50.94	-36.79	-37.93	-10.96
Operating Margin (%)	3.24	3.78	-15.49	-21.13	-23.67	-129.18	-120.78	-81.51	-73.91	-72.47	-29.78	-52.94	-38.11	-39.18	-12.2
Incremental Operating Margin (%)	193.82	9.87	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	0.13	3.01	-25.16	-47.99	-18.11	-130.24	-135.22	-88.47	-70.25	-70.04	-30.55	-51.47	-40.65	-48.45	-20.5
Profit Margin (%)	0.43	2.23	-18.34	-62.43	-18.19	-44.79	-49.46	377.71	-69.79	-42.93	-31.27	-52.09	-35.75	-48.78	-21.22
Net Income to Common Margin (%)	0.43	2.23	-29.4	-65.8	28.33	-44.79	-49.46	377.71	-69.79	-42.93	-31.27	-52.09	-35.75	-48.78	-21.22
Effective Tax Rate (%)	- -	26.02	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	37.61	5.12	164.2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	0.5	2.74	-20.68	-167.99	-43.12	-15.92	-20.98	114.86	-24.88	-17.63	-25.84	-50.79	-58.22	-114.7	-77.99

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	4	3	3	3	3	3	3	- -	1	1	- -	1	39	39	39
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	3	3	3	3	3	3	3	- -	1	- -	- -	1	38	38	39
Total Debt/EBITDA	2.03	1.8	-1.15	-0.69	-0.54	-0.29	-0.24	-0.01	-0.06	-0.04	-0.02	-0.04	-2	-2.12	-6.79
Net Debt/EBITDA	-0.76	-0.39	1.64	0.47	1.38	1.07	0.61	1.28	2.92	2.18	2.28	0.45	0.54	-0.12	-0.54
Total Debt/EBIT	4.31	3.27	-0.89	-0.58	-0.47	-0.27	-0.23	-0.01	-0.05	-0.03	-0.02	-0.03	-1.93	-2.06	-6.1
Net Debt/EBIT	-1.62	-0.71	1.27	0.4	1.22	1	0.58	1.22	2.81	2.09	2.14	0.43	0.52	-0.11	-0.48
EBITDA to Interest Expense	7.38	8.2	-11.98	-32.93	-39.08	-67.46	-85.77	-123.71	-2,514.38	-417.3	-1,354.5	-1,511.47	-7.77	-3.09	-1.04
EBITDA-CapEx/Interest Expense	5.09	4.96	-14.46	-37.11	-41.74	-69.27	-90.36	-127.2	-2,677	-429.93	-1,426.8	-1,578.8	-7.99	-3.21	-1.24
EBIT to Interest Expense	3.47	4.51	-15.47	-38.74	-44.22	-72.1	-90.89	-130.14	-2,608.62	-436.59	-1,444.8	-1,570.8	-8.05	-3.19	-1.15
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	6	6
Common Equity/Total Assets	78.32	81.24	57.48	6.06	74.41	74.69	71.1	90.88	84.09	85.98	78.15	72.59	33.7	21.91	21.75
Long-Term Debt/Equity (%)	15.46	14.33	14.93	67.6	13.13	10.81	11.78	0.16	0.92	0.49	0.03	1.44	141.65	267.94	262.37
Long-Term Debt/Capital (%)	13.32	12.47	12.95	39.14	11.51	9.67	10.44	0.16	0.91	0.48	0.03	1.41	58.29	72.33	71.83
Long-Term Debt/Total Assets (%)	12.11	11.64	9.6	12.78	9.77	8.07	8.37	0.15	0.77	0.42	0.03	1.05	48.12	59.23	58.22
Total Debt/Equity (%)	16.05	14.93	15.27	72.69	14.16	11.72	12.86	0.16	1.59	1.06	0.56	2.11	143.01	270.42	265.26
Total Debt/Capital (%)	13.83	12.99	13.25	42.09	12.4	10.49	11.4	0.16	1.57	1.05	0.56	2.06	58.85	73	72.62
Total Debt/Total Assets (%)	12.57	12.13	9.82	13.74	10.53	8.75	9.15	0.15	1.34	0.91	0.44	1.54	48.59	59.78	58.86
Net Debt to Equity	-6.01	-3.25	-21.88	-49.45	-36.28	-43.41	-32.29	-18.88	-82.34	-65.64	-57.16	-26.97	-38.88	15.01	20.96
Net Debt/Capital (%)	-6.4	-3.35	-28.01	-97.81	-56.95	-76.7	-47.7	-23.27	-432.05	-185.3	-131.68	-35.89	-48.08	10.08	13.86
EBITDA	2	2	-3	-5	-6	-11	-12	-13	-20	-19	-14	-23	-19	-18	-6
EBITDA-CapEx	1	1	-3	-6	-7	-11	-12	-13	-21	-20	-14	-24	-20	-19	-7
Operating Income (Loss)	1	1	-4	-6	-7	-11	-12	-14	-21	-20	-14	-24	-20	-19	-6

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.04	2.17	2.72	1.52	2.86	2.74	1.67	9.09	4.78	4.58	2.34	0.86	3.43	2.96	2.71
Current Ratio	6.9	8.45	6.81	4.08	5.35	5.03	3.77	10.43	6.23	7.22	4.6	3.63	5.52	5.26	5
Quick Ratio	2.97	3.66	3.4	2.05	3.57	3.64	2.48	9.68	5.56	6.47	3.94	2.4	4.53	4.4	4.15
CFO/Avg Current Liab	0.84	0.08	-1.05	-0.12	-1.47	-0.6	-0.66	-2.86	-1.77	-1.5	-0.93	-1.62	-0.43	-1.54	-0.71
Common Equity/Total Assets	78.32	81.24	57.48	6.06	74.41	74.69	71.1	90.88	84.09	85.98	78.15	72.59	33.7	21.91	21.75
Long-Term Debt/Equity (%)	15.46	14.33	14.93	67.6	13.13	10.81	11.78	0.16	0.92	0.49	0.03	1.44	141.65	267.94	262.37
Long-Term Debt/Capital (%)	13.32	12.47	12.95	39.14	11.51	9.67	10.44	0.16	0.91	0.48	0.03	1.41	58.29	72.33	71.83
Long-Term Debt/Total Assets (%)	12.11	11.64	9.6	12.78	9.77	8.07	8.37	0.15	0.77	0.42	0.03	1.05	48.12	59.23	58.22
Total Debt/Equity (%)	16.05	14.93	15.27	72.69	14.16	11.72	12.86	0.16	1.59	1.06	0.56	2.11	143.01	270.42	265.26
Total Debt/Capital (%)	13.83	12.99	13.25	42.09	12.4	10.49	11.4	0.16	1.57	1.05	0.56	2.06	58.85	73	72.62
Total Debt/Total Assets (%)	12.57	12.13	9.82	13.74	10.53	8.75	9.15	0.15	1.34	0.91	0.44	1.54	48.59	59.78	58.86
CFO/Total Liabilities	30.98	3.12	-21.41	-2.07	-71.93	-31.92	-41.36	-238.61	-136.99	-156.71	-71.02	-145.04	-10.03	-35.73	-15.38
CFO/CapEx	3.5	0.22	-4.31	-0.66	-13.74	-9.92	-5.94	-57.52	-14.2	-27.65	-14.45	-20.08	-9.85	-25	-7.18
Altman's Z-Score	1.56	1.72	0.59	-0.73	0.02	-1.09	-1.65	1.23	13.53	14.9	18.58	2.59	0.78	-0.34	1.13

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	11.74	10.87	9.73	13.9	12.01	2.3	2.13	3.87	4.82	3.38	4.53	3.77	4.25	3.26	3.28
Days Sales Outstanding	31.1	33.57	37.52	26.25	30.4	158.47	171.02	94.28	75.68	107.92	80.64	96.93	85.85	111.94	111.4
Inventory Turnover	1.86	2.08	1.81	2.64	2.9	0.61	0.63	1.56	2.23	2.24	2.75	1.66	1.71	2.14	2.45
Days Inventory Outstanding	196.21	175.61	201.38	138.1	125.7	597.08	581.15	234.32	163.99	163.05	132.49	220.43	213.23	170.28	149
Accounts Payable Turnover	14.98	16.63	16.46	12.25	12.43	2.77	0.87	3.09	5.73	4.65	8.52	7.7	6.21	6.15	7.35
Accounts Payable Turnover Days	24.36	21.94	22.17	29.8	29.37	131.83	418.1	117.95	63.69	78.42	42.85	47.42	58.75	59.34	49.68
Cash Conversion Cycle	202.95	187.24	216.72	134.55	126.73	623.73	334.07	210.65	175.98	192.54	170.29	269.94	240.33	222.87	210.72
Inventory to Cash Days	-165.11	-142.04	-163.86	-111.84	-95.31	-438.61	-410.13	-140.04	-88.32	-55.13	-51.86	-123.5	-127.38	-58.34	-37.61
Inventories	8	8	8	6	6	6	4	3	5	4	7	12	10	8	9
Raw Materials	5	5	5	4	5	5	5	3	3	2	4	5	4	4	5
Work In Process	2	1	1	1	- -	- -	- -	- -	1	1	1	2	2	2	2
Finished Goods	2	2	2	1	2	3	1	1	1	1	2	5	4	3	3
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	289	247	441	81	91	60	146
- Cash & Cash Equivalents	5	4	8	6	12	14	10	17	59	42	31	10	44	32	32
+ Preferred Equity and Hybrid Capital	- -	- -	2	3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	4	3	3	3	3	3	3	- -	1	1	- -	1	39	39	39
Enterprise Value	-1	-1	-2	1	-8	-11	-7	-78	231	206	411	72	86	67	154
Total Capital	26	26	25	8	27	29	25	87	72	65	54	39	65	53	54
Total Debt/Capital (%)	13.83	12.99	13.25	42.09	12.4	10.49	11.4	0.16	1.57	1.05	0.56	2.06	58.85	73	72.62
Total Debt / EV	-2.67	-4.6	-1.35	3.93	-0.39	-0.27	-0.4	- -	- -	- -	- -	0.01	0.45	0.58	0.26
EV/Sales	- -	- -	- -	0.03	- -	- -	- -	- -	8.2	7.43	8.47	1.61	1.64	1.39	2.92
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	2.12	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	288	246	440	81	91	56	144
Diluted Enterprise Value	-1	-1	-2	1	-8	-11	-7	-16	231	205	410	72	86	63	152
EV per Share	- -	- -	- -	0.05	- -	- -	- -	- -	6.77	6	11.94	2.07	2.48	1.77	3.69
TTM Sales	25	28	24	28	30	9	10	17	28	28	49	45	52	48	53
TTM EBITDA	2	2	-3	-5	-6	-11	-12	-13	-20	-19	-14	-23	-19	-18	-6
TTM Operating Income	1	1	-4	-6	-7	-11	-12	-14	-21	-20	-14	-24	-20	-19	-6
TTM Cash Flow to Firm	3	- -	-2	- -	-6	-3	-4	-21	-18	-16	-10	-20	-3	-12	-2
TTM Free Cash Flow to Firm	3	1	-2	- -	-5	-2	-3	-20	-17	-15	-10	-19	-3	-11	-1

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	-16.78	-15.91	-45.25	-4.19	-19.23	-3.24	-20.88
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-1	-1	-2	1	-8	-11	-7	-78	231	206	411	72	86	67	154
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	3.55	2.81	6.71	1.31	1.41	0.97	0.76
EV/Sales	- -	- -	- -	0.03	- -	- -	- -	- -	8.2	7.43	8.47	1.61	1.64	1.39	2.92
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	-11.87	-16.13	-25.17	-9.37	-6.97	-2.36	-7.75
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	-15.37	-24.7	-39.6	-20.52	-14.75	-4.24	-16.28
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	-6.14	-8.08	-15.18	-1.95	-2.61	-1.46	-2.77
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	4.06	3.87	8.21	2.15	3.4	4.2	10.06
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	3.29	3.02	7.13	5.79	4.88	4.15	6.08
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	4.26	4.62	11.21	12.69	10.34	7.45	12.76
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	1.7	1.51	4.3	1.21	1.83	2.57	2.17
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	4.06	3.87	8.21	2.15	3.4	4.2	10.06
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	3.29	3.02	7.13	5.79	4.88	4.15	6.08
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	4.26	4.62	11.21	12.69	10.34	7.45	12.76
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	1.7	1.51	4.3	1.21	1.83	2.57	2.17
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	10.21	8.89	9.07	1.81	1.73	1.17	2.72
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	8.29	6.93	7.87	4.88	2.49	1.15	1.64
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	10.73	10.61	12.38	10.69	5.27	2.07	3.45
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	4.28	3.47	4.75	1.02	0.93	0.71	0.59
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	-15.6	-15.33	-42.12	-3.98	-17.28	-3.11	-17.98
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	-12.66	-11.94	-36.54	-10.71	-24.83	-3.07	-10.86
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	-16.39	-18.29	-57.5	-23.45	-52.57	-5.51	-22.8
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	-6.55	-5.98	-22.05	-2.23	-9.3	-1.9	-3.88
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	-13.62	-12.39	-39.26	-11.27	-27.64	-3.2	-12.62
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	-17.64	-18.98	-61.77	-24.68	-58.51	-5.74	-26.49
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	-7.04	-6.21	-23.69	-2.35	-10.35	-1.98	-4.51
EV/Sales Average	- -	- -	- -	0.03	- -	- -	- -	- -	6.27	5.46	7.26	4.68	2.4	1.37	1.82
EV/Sales High	- -	- -	- -	0.03	- -	- -	- -	- -	8.72	9.15	11.79	10.5	5.18	2.35	3.66
EV/Sales Low	- -	- -	- -	0.03	- -	- -	- -	- -	2.25	1.99	4.14	0.81	0.84	0.91	0.75
EV/EBITDA Average	-0.76	-0.39	0.85	-0.17	1.38	1.07	0.61	1.28	-8.8	-7.88	-26.02	-9.2	-6.52	-3.62	-16.62
EV/EBITDA High	-0.76	-0.39	0.85	-0.17	1.38	1.07	0.61	1.28	-12.23	-13.2	-42.22	-20.62	-14.08	-6.19	-33.4
EV/EBITDA Low	-0.76	-0.39	0.85	-0.17	1.38	1.07	0.61	1.28	-3.16	-2.88	-14.81	-1.59	-2.28	-2.39	-6.81
EV/EBIT Average	-1.62	-0.71	0.66	-0.15	1.22	1	0.58	1.22	-8.48	-7.53	-24.4	-8.85	-6.29	-3.51	-14.93
EV/EBIT High	-1.62	-0.71	0.66	-0.15	1.22	1	0.58	1.22	-11.79	-12.62	-39.58	-19.84	-13.59	-5.99	-30.01
EV/EBIT Low	-1.62	-0.71	0.66	-0.15	1.22	1	0.58	1.22	-3.05	-2.75	-13.89	-1.53	-2.2	-2.32	-6.12
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	8.46	7.2	12.82	2.34	2.62	1.58	3.5
High Price	- -	- -	- -	- -	- -	- -	- -	- -	8.89	8.59	17.5	13.78	7.97	2.8	4.44
Enterprise Value Average	-1	-1	-2	1	-8	-11	-7	-16	177	151	352	209	125	66	96
Enterprise Value High	-1	-1	-2	1	-8	-11	-7	-16	246	253	572	468	271	113	193
Enterprise Value Low	-1	-1	-2	1	-8	-11	-7	-16	64	55	201	36	44	44	39

Shares Outstanding	18	18	18	18	27	31	33	34	34	34	34	35	35	38	42
Diluted Weighted Avg Shares	18	18	18	18	28	27	31	34	34	34	34	35	35	36	41
Basic Weighted Avg Shares	18	18	18	18	24	27	31	33	34	34	34	35	35	36	41
Revenue per Share	1.44	1.57	1.34	1.56	1.21	0.32	0.33	0.5	0.83	0.81	1.41	1.29	1.51	1.35	1.29
EBITDA per Share	0.1	0.11	-0.16	-0.28	-0.25	-0.39	-0.37	-0.39	-0.59	-0.56	-0.39	-0.66	-0.56	-0.51	-0.14
Operating Income per Share	0.05	0.06	-0.21	-0.33	-0.29	-0.42	-0.39	-0.41	-0.61	-0.59	-0.42	-0.68	-0.58	-0.53	-0.16
Basic EPS, GAAP	0.01	0.03	-0.39	-1.03	0.34	-0.14	-0.16	1.89	-0.58	-0.35	-0.44	-0.67	-0.54	-0.66	-0.27
Basic EPS from Cont Ops	0.01	0.03	-0.25	-0.97	-0.22	-0.42	-0.44	-0.32	-0.58	-0.35	-0.44	-0.67	-0.54	-0.66	-0.27
Diluted EPS, GAAP	0.01	0.03	-0.39	-1.03	0.3	-0.14	-0.16	1.83	-0.58	-0.35	-0.44	-0.67	-0.54	-0.66	-0.27
Diluted EPS from Cont Ops	0.01	0.03	-0.25	-0.97	-0.19	-0.42	-0.44	-0.31	-0.58	-0.35	-0.44	-0.67	-0.54	-0.66	-0.27
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.11	0.01	-0.14	-0.02	-0.24	-0.1	-0.12	-0.63	-0.54	-0.47	-0.3	-0.59	-0.15	-0.51	-0.19
Free Cash Flow per Basic Share	0.08	-0.03	-0.18	-0.06	-0.26	-0.11	-0.14	-0.64	-0.58	-0.49	-0.33	-0.62	-0.17	-0.53	-0.22
Cash & Equivalents per Share	0.28	0.24	0.45	0.32	0.44	0.47	0.3	2.32	1.72	1.22	0.9	0.29	1.26	0.84	0.76
Book Value per Share	1.26	1.3	1.08	0.08	0.87	0.85	0.67	2.59	2.09	1.86	1.56	1.09	0.77	0.38	0.35
Tangible Book Value per Share	1.13	1.17	0.96	-0.02	0.79	0.79	0.66	2.58	2.09	1.86	1.56	1.09	0.77	0.38	0.35

Apyx Medical Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)